Financial Trade Freedom - Investing and Stock News
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
No Result
View All Result
Financial Trade Freedom - Investing and Stock News
No Result
View All Result
Home Stock

US stocks extends gains on Palantir Surge even with tariff concerns

admin by admin
August 5, 2025
in Stock
0
US stocks extends gains on Palantir Surge even with tariff concerns
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

US markets opened in the green, extending gains from Monday, lifted by a rally in Palantir shares, while broader market sentiment was pressured by renewed tariff threats from President Donald Trump and underwhelming earnings from several major industrial names.

The tech-heavy Nasdaq index gained 0.23% at the open. The S&P 500 index was up 0.16% while the Dow Jones Industrial Average rose 0.14%.

Palantir leads tech gains

Shares of Palantir Technologies jumped nearly 8% after the defense technology firm reported quarterly revenue surpassing $1 billion for the first time.

The company also topped second-quarter earnings expectations and raised full-year guidance, fueling investor optimism.

Other corporate results painted a mixed picture.

Pfizer rose 3.8% after posting earnings and revenue above forecasts and lifting its full-year earnings outlook.

Dupont De Nemours gained 3.3% on better-than-expected quarterly results, while Axon Enterprise surged 14% after beating estimates and raising its full-year guidance.

Lemonade also saw a sharp rise, gaining 30% as second-quarter revenue exceeded estimates and losses narrowed more than analysts anticipated.

On the downside, Caterpillar shares gained 0.76% after reporting weaker-than-expected earnings.

Yum Brands fell 3.4% following a miss on both earnings and revenue. Eaton dropped 6.5% after issuing softer-than-expected third-quarter guidance despite topping second-quarter estimates.

Hims & Hers Health saw one of the steepest declines, sliding 6.4% as its second-quarter revenue and EBITDA forecast both came in below expectations.

Trump’s tariff comments pressure sentiment

Market sentiment was tempered by comments from President Trump, who told CNBC that new tariffs on semiconductors and pharmaceuticals are imminent.

“We’re going to be announcing on semiconductors and chips, which is a separate category, because we want them made in the United States,” Trump said, adding that the plan would be unveiled “within the next week or so.”

On pharmaceuticals, the president indicated that tariffs could eventually reach as high as 250%, the steepest rate he has proposed to date.

The remarks come amid heightened trade policy activity that has already unsettled markets.

Last week, stocks fell sharply following tariff announcements and a weak jobs report, raising concerns over economic momentum.

While the S&P 500 rebounded 1.5% on Monday, snapping a four-day losing streak, analysts remain cautious about potential volatility through August.

Trump also revealed he is considering four candidates for the next Federal Reserve chair, excluding Treasury Secretary Scott Bessent, who he said wishes to remain in his current role.

Earnings season nears final stretch

As of Tuesday, 370 companies in the S&P 500 had reported second-quarter results, with more than 81% beating analyst expectations, according to FactSet.

Investors are now awaiting reports from several notable names, including Snap, Advanced Micro Devices, and Rivian, scheduled for release after the close.

While the Nasdaq managed a modest gain on Tuesday, aided by strength in tech names, the broader market’s performance reflected lingering investor caution amid the intersection of earnings uncertainty and looming trade policy changes.

The post US stocks extends gains on Palantir Surge even with tariff concerns appeared first on Invezz


Previous Post

Novo Nordisk stock downgraded as Trump teases 250% pharma tariffs

Next Post

Pfizer stock pops as big pharma giant delivers post-COVID comeback

Next Post
Pfizer stock pops as big pharma giant delivers post-COVID comeback

Pfizer stock pops as big pharma giant delivers post-COVID comeback

  • Trending
  • Comments
  • Latest
U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

February 19, 2025
How Companies Use Derivatives To Hedge Risk

How Companies Use Derivatives To Hedge Risk

February 19, 2025
As Joann Fabrics and JCPenney announce store closings, here’s what’s driving the pattern

As Joann Fabrics and JCPenney announce store closings, here’s what’s driving the pattern

February 17, 2025
KFC moves U.S. headquarters from Kentucky to Texas

KFC moves U.S. headquarters from Kentucky to Texas

February 19, 2025
Pfizer stock pops as big pharma giant delivers post-COVID comeback

Pfizer stock pops as big pharma giant delivers post-COVID comeback

0
From tariffs to DOGE, what companies are saying about the impact of MAGA policies

From tariffs to DOGE, what companies are saying about the impact of MAGA policies

0
Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

0
Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

0
Pfizer stock pops as big pharma giant delivers post-COVID comeback

Pfizer stock pops as big pharma giant delivers post-COVID comeback

August 5, 2025
US stocks extends gains on Palantir Surge even with tariff concerns

US stocks extends gains on Palantir Surge even with tariff concerns

August 5, 2025
Novo Nordisk stock downgraded as Trump teases 250% pharma tariffs

Novo Nordisk stock downgraded as Trump teases 250% pharma tariffs

August 5, 2025
Yum Brands shares plunge 3% after Q2 earnings miss

Yum Brands shares plunge 3% after Q2 earnings miss

August 5, 2025

    Get Smarter with Your Money – Sign Up for Free Financial Tips!


    Join our community of savvy savers and investors! By signing up, you'll receive weekly emails packed with personalized financial tips, budgeting hacks, and investment strategies tailored to your income level. Take control of your finances today – it’s free and only takes a minute!

    Recent News

    Pfizer stock pops as big pharma giant delivers post-COVID comeback

    Pfizer stock pops as big pharma giant delivers post-COVID comeback

    August 5, 2025
    US stocks extends gains on Palantir Surge even with tariff concerns

    US stocks extends gains on Palantir Surge even with tariff concerns

    August 5, 2025
    Novo Nordisk stock downgraded as Trump teases 250% pharma tariffs

    Novo Nordisk stock downgraded as Trump teases 250% pharma tariffs

    August 5, 2025
    Yum Brands shares plunge 3% after Q2 earnings miss

    Yum Brands shares plunge 3% after Q2 earnings miss

    August 5, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved

    No Result
    View All Result
    • About us
    • Contacts
    • Email Whitelisting
    • Investing and Stock News
    • Privacy Policy
    • Terms and Conditions
    • Thank you

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved